West Pharmaceutical Services Inc.
WST | NYSE
$364.51
+$2.20 (+0.61%)
Sep 21, 2026, 12:35 PM ET · Market open
Market Data
Market Cap $25.49B
Enterprise Value $25.36B
Beta 1.14
Average Volume 719.42K
Shares Outstanding (Diluted) 71.3M
Shares Change YoY -2.06%
Institutional Ownership 98.74%
Exchange NYSE
ISIN US9553061055
Price Performance
Price Change 1M 3.1%
Price Change 3M 9.8%
Price Change 6M 50.0%
Price Change YTD 31.0%
Price Change 1Y 42.0%
Price Change 3Y -2.8%
Price Change 5Y -20.8%
1M CAGR (ann.) 3.9%
1Y CAGR (ann.) 41.6%
5Y CAGR (ann.) -4.4%
All-Time CAGR 16.5%
Valuation
PE Ratio 46.31
Forward PE 36.01
PEG Ratio 2.69
Forward PEG 4.04
PS Ratio 7.66
Forward PS 7.10
PB Ratio 8.52
P/FCF Ratio 58.34
P/Adj. FCF Ratio 63.04
P/OCF Ratio 38.73
EV/Sales 7.62
EV/EBIT 36.78
EV/EBITDA 30.77
EV/FCF 58.05
Earnings Yield 2.2%
FCF Yield 1.7%
Adj. FCF Yield 1.6%
Financial Health
Net Cash $123.7M
Total Debt $312.1M
Cash & Short-Term Investments $435.8M
Total Assets $4.08B
Current Ratio 2.82
Quick Ratio 2.12
Debt / Equity Ratio 0.10
Debt / EBITDA 0.38
Debt / FCF 0.71
OCF / Debt 2.12
Interest Coverage 6,865.00
Altman Z-Score 17.38
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 36.8%
Operating Profit Margin 20.6%
EBITDA Margin 24.8%
Net Profit Margin 17.0%
FCF Margin 13.1%
Adj. FCF Margin 12.2%
SBC / Revenue 1.0%
SBC Impact (per share) -7.5%
Returns
Return on Assets 13.9%
Return on Equity 18.5%
Return on Invested Capital 15.8%
Return on Capital Employed 20.0%
Return on Tangible Assets 14.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 5.1%
Revenue CAGR 5Y 5.7%
Revenue CAGR 10Y 8.6%
EPS CAGR 3Y 4.5%
EPS CAGR 5Y 2.7%
EPS CAGR 10Y 19.0%
FCF CAGR 3Y 3.3%
FCF CAGR 5Y 8.7%
FCF CAGR 10Y 20.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 16
EPS Growth Next 3Y 18.1%
Revenue Growth Next 3Y 8.0%
Earnings Date Oct 21, 2026
EPS Estimate (next Q) $2.18
EPS Growth Est (next Q) 11.2%
Revenue Est (next Q) $825.98M
Revenue Growth Est (next Q) 2.7%
Fair Value Estimates
Graham Number $86.20
Graham Upside -76.2%
Lynch Fair Value $39.10
Lynch Upside -89.2%
Price Target $407
Price Target Upside 12.4%
Cash Flow
Operating Cash Flow $662.2M
Free Cash Flow $436.9M
Adj. Free Cash Flow $404.3M
FCF Per Share $6.17
OCF Per Share $9.35
OCF/S Ratio 19.9%
Income Statement
Revenue $3.33B
Gross Profit $1.22B
Operating Income $686.5M
EBITDA $824.2M
Net Income $564.9M
EPS (Diluted) $7.82
Revenue / Employee $308.01K
Profit / Employee $52.31K
Employees 10,800
Dividends
Annual Dividend $0.88
Dividend Yield 0.24%
Payout Ratio 11.3%
FCF Payout Ratio 14.3%
Adj. FCF Payout Ratio 15.4%
Dividend Growth (YoY) 4.8%
Pay Frequency Quarterly
Ex-Dividend Date Jul 28, 2026
Add to Watchlist
Select watchlists to add or remove WST